V

VHsquared Ltd.

50 employees

VHsquared is dedicated to the development of novel antibody domains engineered to be stable in the GI tract.

Basic info

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2010

Funding rounds raised

V

VHsquared Ltd. raised undisclosed on April 13, 2016

Investors: SV Life Sciences

V

VHsquared Ltd. raised undisclosed on December 30, 2013

Investors: Lundbeckfonden / Lundbeck Foundation, Takeda UK Limited, S.R. One Ltd, Unilever Ventures and SV Life Sciences

FAQ